Complications of blind versus ultrasound-guided percutaneous liver biopsy in children

Honar, Naser; Jooya, Parisa; Haghighat, Mahmood; Imanieh, Mohammad Hadi; Dehghani, Seyed Mohsen; Zahmatkeshan, Mozhgan; Javaherizadeh, Hazhir

doi:10.1016/j.ajg.2015.09.009

Cited by 8 publications

(8 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nobili et al, in a retrospective review of PLBs in children, also reported a significantly higher incidence of haemorrhagic complications and technical failure in unguided biopsies in comparison with sonographically guided biopsies [8]. Furthermore, several authors in the adult literature reported a significantly higher incidence of complications when sonographic guidance was not used (2.2-7.7% vs. 0.5-2%) [3,6,12,20,29].…”

Section: Discussionmentioning

confidence: 99%

“…Regarding the financial cost related to the addition of US to the procedure, Younossi et al and Pasha et al showed that the cumulative cost for all patients is less than the potential cost for treatment of major complications [3,6].…”

Section: Discussionmentioning

confidence: 99%

“…Some evidence suggests that the risk of bleeding requiring transfusion may be higher in children than in adults [5][6].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Percutaneous Liver Biopsy in Infants: A Single Center Experience

Francesco¹,

Farris²,

Morandi³

et al. 2017

JGPLD

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous Liver Biopsy in Infants: A Single Center Experience

Francesco¹,

Farris²,

Morandi³

et al. 2017

JGPLD

View full text Add to dashboard Cite

show abstract

“…In the absence of strong evidence-based recommendations for biopsies in children, Robertson et al proposes in 2007 several criteria: young age (less than 10 years old), a family record of severe registered NAFLD, the existence of hepatosplenomegaly on physical examination, and modified biochemical markers (such as marked/persistent elevated transaminases, insulin resistance, presence of nonspecific autoantibodies) [ 35 ]. However, the use of LB in the pediatric population is limited because of the method invasiveness and the risk of association with major complications, such as bleeding, which can occur in both adults and children [ 36 ].…”

Section: ⧉ Diagnosismentioning

confidence: 99%

Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm

Trandafir

Frăsinariu

Leon-Constantin³

et al. 2021

Rom J Morphol Embryol

View full text Add to dashboard Cite

Worldwide, nonalcoholic fatty liver disease (NAFLD) has emerged as the leading cause of chronic liver disease in children and adolescents, but also as a real public health issue. Over the last decades, the increase in the rates of obesity and overweight in children has led to the increase in the worldwide prevalence of pediatric NAFLD. Detection of a hyperechoic appearance of the liver at ultrasounds or elevated levels of transaminases, identified during a routine control in children, suggests NAFLD. The disorder can be diagnosed with either non-invasive strategies or through liver biopsy, which further allows the identification of specific histological aspects, distinct from those found in adults. Since NAFLD is a clinically heterogeneous disease, there is an imperative need to identify noninvasive biomarkers and screening techniques for early diagnosis in children, in order to prevent metabolic and cardiovascular complications later in adulthood. This review emphasizes the main diagnosis tools in pediatric NAFLD, a systemic disorder with multifactorial pathogenesis and varying clinical manifestations.

show abstract

“…6 Fibroscopy (transient elastography) is a novel noninvasive method used to evaluate the degree of liver fibrosis. 7 The fundamental principle of fibroscopy is a one-dimensional transient elastronic wave, which measures variations in the liver stiffness in kPa (LSM), in response to the changes in the speed of transient elastography. 8 In the past few years, fibroscopy has been more frequently used to evaluate various liver diseases, in comparison with biopsy and other diagnostic modalities.…”

Section: Introductionmentioning

confidence: 99%

Diagnostic Performance of Noninvasive Methods for Liver Biopsy by Fibroscan in Pediatric

Heidari

Motamed

Heirati

et al. 2021

Journal of Child Science

View full text Add to dashboard Cite

Liver biopsy is the gold standard for the diagnosis and management of various liver diseases; however, noninvasive diagnostic modalities may help prevent adverse effects of anesthesia, prolonged hospitalization, sampling error, and other serious complications, particularly in pediatric patients. The aim of this study is to compare the results of liver biopsy and fibroscan in children with chronic liver diseases. All patients presenting chronic liver disease admitted in the ward or clinic of Tehran's Children Medical Center were enrolled in the study. Required laboratory tests were performed to diagnose the disease, followed by elastography using fibroscan 402 (M-probe) Echosens machine and liver biopsy using Menghini technique. Samples were scored by using METAVIR scoring system. Thirty-two patients were reported (68.8%, female) with autoimmune hepatitis (18.8%), Wilson disease (12.5%), and glycogen storage disease (12.5%). The most common pathologic stage and fibroscan result was stage III and F0 (46.9%), respectively. Association between pathology and fibroscan results was not significant. Nonetheless, age and diagnosis, age and Fibroscan score, and pathology and liver function test were significantly associated with each other. Fibroscan cannot be used as an alternative to liver biopsy; however, it can be a useful accessory tool.

show abstract

Complications of blind versus ultrasound-guided percutaneous liver biopsy in children

Cited by 8 publications

References 29 publications

Percutaneous Liver Biopsy in Infants: A Single Center Experience

Percutaneous Liver Biopsy in Infants: A Single Center Experience

Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm

Diagnostic Performance of Noninvasive Methods for Liver Biopsy by Fibroscan in Pediatric

Contact Info

Product

Resources

About